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Cardiac resynchronization therapy (CRT) has been used extensively over the last years in
the therapeutic management of patients with end-stage heart failure. Data from 4,017
patients have been published in eight large, randomized trials on CRT. Improvement in
clinical end points (symptoms, exercise capacity, quality of life) and echocardiogra-
phic end points (systolic function, left ventricular size, mitral regurgitation) have been
reported after CRT, with a reduction in hospitalizations for decompensated heart failure
and an improvement in survival. However, individual results vary, and 20% to 30% of
patients do not respond to CRT. At present, the selection criteria include severe heart
failure (New York Heart Association functional class III or IV), left ventricular ejection
fraction 35%, and wide QRS complex (120 ms). Assessment of inter- and particularly
intraventricular dyssynchrony as provided by echocardiography (predominantly tissue
Doppler imaging techniques) may allow improved identification of potential responders
to CRT. In this review a summary of the clinical and echocardiographic results of the
large, randomized trials is provided, followed by an extensive overview on the currently
available echocardiographic techniques for assessment of LV dyssynchrony. In addition,
the value of LV scar tissue and venous anatomy for the selection of potential candidates
for CRT are discussed. (J Am Coll Cardiol 2005;46:2153– 67) © 2005 by the American
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.09.019College of Cardiology Foundation
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Mardiac resynchronization therapy (CRT) has changed the
reatment of patients with end-stage, drug-refractory heart
ailure. To date, eight large randomized, clinical trials in
RT have been completed (1–8). A summary of these
rials, with a total of 4,017 patients, is provided in Table 1.
he inclusion criteria in these trials were:
From the *Department of Cardiology, Leiden University Medical Center, Leiden,
he Netherlands; †Johns Hopkins University, Baltimore, Maryland; ‡University of
outh Florida, Tampa, Florida; §University of Klinikum Mannheim, Mannheim,
ermany; The Chinese University of Hong Kong, Hong Kong, China; ¶Hopital
ardiologique du Haut-Leveque, Pessac, France; #University of Pittsburgh, Pitts-
urgh, Pennsylvania; **Mayo Clinic, Rochester, Minnesota; ††Turku PET Center,
niversity of Turku, Turku, Finland; ‡‡Hopital Pontchaillou, Rennes, France;
§Karolinska University Hospital, Stockholm, Sweden; Duke Clinical Research
nstitute, Durham, North Carolina; ¶¶King’s College Hospital, London, United
ingdom; ***Hammersmith Hospital, London, United Kingdom; and †††Stadtische
liniken Bielefeld, Bielefeld, Germany.
Dr. Abraham receives honoraria from GE, Guidant, Medtronic, St. Jude andeceives research support from Guidant; Dr. Barold received lecture fees from
edtronic; Dr. Breithardt has been a consultant for Medtronic and Guidant and has 2evere heart failure, New York Heart Association (NYHA)
functional class III and IV
epressed systolic left ventricular (LV) function, LV ejec-
tion fraction (LVEF) 35%
ide QRS complex: 120 ms with interventricular con-
duction disorder
esearch affiliations with Medtronic, Guidant, and GE Vingmed; Dr. Hayes is on the
dvisory board of Guidant Inc. and has been a speaker for Guidant Inc., Medtronic
nc., St. Jude Medical, and ELA Medical, and has received royalties from Blackwell
utura; Dr. Gorcsan received research grant support from GE, Toshiba, Siemens,
edtronic, and St. Jude; Dr. Kass has been a consultant for Guidant Inc.; Dr. Mark
as been a consultant and received grants from Medtronic, Inc. Dr. Monaghan has
eceived support from Philips, GE, Siemens, Guidant, Medtronic, and Accusphere;
r. Schalij is on the advisory board of Guidant and has received research grants from
edtronic, Guidant, and St. Jude; Dr. Stellbrink is a sponsored investigator for
uidant, Medtronic, St. Jude, and Biotronik and is also an advisor to Guidant and
iotronik; Dr. Nihoyannopoulos received research grants and consultant fees from
edtronic.
Manuscript received April 19, 2005; revised manuscript received September 19,
005, accepted September 19, 2005.
H
t
p
N
a
m
w
l
a
a
p
i
r
r
S
I
(
D
C
M
u
c
d
s
C
e
L
L
M
e
d
g
e
e
L
o
c
t
s
e
i
3
e
e
t
s
W
S
a
r
m
t
n
c
s
4
t
m
u
i
I
L
i
R
a
c
o
l
m
t
r
b
i
c
a
C
p
t
w
e
i
c
c
Q
T
2154 Bax et al. JACC Vol. 46, No. 12, 2005
Issues Before Device Implantation December 20, 2005:2153–67The Cardiac Resynchronization-Heart Failure (CARE-
F) study is the only study that, to some extent, has included
he presence of LV dyssynchrony in the inclusion criteria.
In these large trials, the most frequently used primary end
oints mainly reflect the functional status (6-min walk test,
YHA functional class, quality of life score, and peak O2)
nd should be considered clinical end points. The vast
ajority of studies demonstrated improvement in 6-min
alking distance, NYHA functional class, and quality of
ife score. In addition, the majority of studies that evalu-
ted peak O2 reported an improvement in this parameter
fter CRT.
Few studies have focused on morbidity and mortality. In
articular, the recent CARE-HF study has focused primar-
ly on morbidity and mortality (6). Inconsistency on the
eduction in hospital admissions has been reported. While a
eduction in hospitalizations was observed in the Multisite
imulation in Cardiomyopathies (MUSTIC) and Multicenter
nSync Randomized Clinical Evaluation (MIRACLE) trials
2,3), this was not the case in the CONTAK-Cardiac
efibrillator (CONTAK-CD) and MIRACLE-Implantable
ardioverter Defibrillator trials (4,8). The Comparison of
edical Therapy, Pacing and Defibrillation in Heart Fail-
re (COMPANION) trial demonstrated a reduction in the
omposite end point of all-cause mortality or hospitalization
uring 16 months follow-up (5). The CARE-HF study
ubsequently demonstrated a clear survival benefit after
RT as compared to optimized medical therapy (6).
Secondary end points in the studies were predominantly
chocardiographic measurements including:
V systolic function, LVEF,
V reverse remodeling, LV volumes,
itral regurgitation
In these large randomized trials, detailed information on
chocardiographic data is not consistently available, but
etailed echocardiographic studies have been performed. In
eneral, LV systolic function improved, LV reverse remod-
ling occurred, and mitral regurgitation decreased. How-
ver, the extent of improvement in LVEF and reduction in
V volumes varied substantially among studies.
Based on the available trials, the current American College
Abbreviations and Acronyms
CMR  cardiovascular magnetic resonance
CRT  cardiac resynchronization therapy
LV  left ventricle/ventricular
LVEF  left ventricular ejection fraction
MIRACLE  Multicenter InSync Randomized Clinical
Evaluation study
MSCT  multislice computed tomography
NYHA  New York Heart Association
TDI  tissue Doppler imaging
TSI  tissue synchronization imagingf Cardiology/American Heart Association/North Ameri- pan Society of Pacing and Electrophysiology guidelines state
hat CRT is beneficial in patients with heart failure, severe
ystolic LV dysfunction, and wide QRS complex (level of
vidence class IB). Although the results are indeed prom-
sing, analysis of individual responses revealed that 20% to
0% of patients do not respond to CRT (3,9). Accordingly,
mphasis has shifted towards selection of potential respond-
rs to CRT, before device implantation. Before discussing
he identification of responders, the definition of a re-
ponder should be addressed.
HO IS A RESPONDER TO CRT?
mall studies have initially used invasive methods to
ssess acute hemodynamic response to CRT. Long-term
esponse (usually assessed at three to six months of CRT) is
ainly evaluated by clinical or echocardiographic parame-
ers (Table 2). The relationship between acute hemody-
amic response and chronic outcomes is still not entirely
lear.
Clinical parameters are subjective and mainly reflect
ymptoms; a substantial placebo effect may be present in
0% of individuals (3). Still, these are the criteria that are
raditionally used to evaluate patients with heart failure, and
ay be most relevant from a patient perspective. The
ltimate clinical end points include a reduction in hospital-
zation and mortality rate.
Echocardiographic parameters may be more objective.
mprovements in LV systolic function (mainly expressed as
VEF) have been reported in most studies, but the absolute
ncrease in LVEF varied substantially among studies (3,6,8).
everse LV remodeling (indicated by a decrease in LV systolic
nd diastolic diameters and volumes) has been reported
onsistently in CRT studies and often used as an indicator
f response (2,3,6,8). Indeed, molecular changes in the
ateral wall of the LV such as increased stress kinase levels
ay decrease after CRT. Whether these changes contribute
o the reverse LV remodeling or are merely a result of the
everse remodeling is yet unclear. Echocardiography has also
een used to demonstrate improvements in inter- and
ntraventricular dyssynchrony (10).
Clinical non-responders have also been reported when
orrelated with echocardiographic results. Yu et al. (11) used
15% improvement in LV end-systolic volume index after
RT and demonstrated non-response in 13 of 30 (43%)
atients. Moreover, clinical and echocardiographic response
o CRT may not always appear simultaneously, and patients
ho respond clinically may not exhibit reverse LV remod-
ling and vice versa. It appears that more patients exhibit
mprovement in clinical parameters as compared to echo-
ardiographic markers. This discrepancy may even further
omplicate the definition of response to CRT.
RS DURATION TO PREDICT RESPONSE TO CRT
he response to CRT was initially considered to result in
art from resynchronization of interventricular dyssyn-
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December 20, 2005:2153–67 Issues Before Device Implantationhrony (dyssynchrony between the left and right ventricle).
hus, patients with interventricular dyssynchrony were
elected for CRT. This selection was based on the QRS
uration, because this parameter is considered to reflect
nterventricular dyssynchrony. Indeed, Rouleau et al. (12)
emonstrated a good relation between interventricular dys-
ynchrony (assessed by tissue Doppler imaging [TDI]) and
RS duration. Accordingly, patients with wide QRS were
onsidered candidates for CRT. In general, studies used
RS duration 120 to 130 ms as a selection criterion. The
able 1. CRT in Randomized Clinical Trials
Trials Design Patients (n) Pri
ATH-CHF (1) Crossover 41 6MWT
Peak VO2
USTIC-SR (2) Crossover 58 6MWT
IRACLE (3) Parallel arms 453 6MWT
NYHA fun
QOL
IRACLE-ICD (4) Parallel arms 555 6MWT
NYHA fun
QOL
OMPANION (5) Parallel arms 1,520 All-cause m
hospitali
ARE-HF (6) Open label,
randomized
814 All-cause m
ATH-CHF II (7) Crossover (no pacing
vs. LV pacing)
86 6MWT
Peak VO2
ONTAK-CD (8) Crossover, parallel
controlled
490 6MWT
NYHA fun
QOL
ARE-HF  Cardiac Resynchronization-Heart Failure; CONTAK-CD  CONTA
efibrillation in Heart Failure; CRT  cardiac resynchronization therapy; LV  left
jection fraction; LVESV  left ventricular end-systolic volume; MIRACLE  Mul
mplantable Cardioverter Defibrillator trial; MR  mitral regurgitation; MUSTIC
ATH-CHF  Pacing Therapies in Congestive Heart Failure trial; QOL  qualit
achycardia; 6MWT  6-min walk test.nitial studies required the presence of a left bundle branch Qlock pattern on the electrocardiogram, whereas more recent
tudies also included patients with non-specific interventric-
lar conduction delay (a poorly defined entity) or even right
undle branch block pattern. The beneficial effect of CRT
n symptoms, exercise capacity, systolic LV function, and
ospitalization rate was demonstrated in these patients with
ide QRS complex, as outlined in the preceding text (Table
). In addition, data from the Pacing Therapies in Conges-
ive Heart Failure (PATH-CHF) II trial demonstrated that
he benefit of CRT was most pronounced in patients with
End Points
Results SummarySecondary
NYHA functional class
QOL
Hospitalizations
Improvement in
6MWT
NYHA functional class
QOL
Less hopitalizations
NYHA functional class
QOL
Peak VO2
LV volumes
MR
Hospitalizations
Total mortality
Improvement in
6MWT
NYHA functional class
QOL
Peak VO2
LV volumes
MR
Less hospitalizations
al class
Peak VO2
LVEF
LVEDD
MR
Clinical composite response
Improvement in
6MWT
NYHA functional class
QOL
LVEF
LVEDD
MR
al class
Peak VO2
LVEF
LV volumes
MR
Clinical composite response
Improvement in
NYHA functional class
QOL
ity or All-cause mortality and cardiac
morbidity
Reduced all-cause mortality/
hospitalization
ity NYHA functional class
QOL
LVEF
LVESV
Hospitalization for heart failure
Reduced mortality/morbidity
Improvement in
NYHA functional class
QOL
LVEF
LVESV
NYHA functional class
QOL
Improvement in
6MWT
QOL
Peak VO2
al class
LVEF
LV volumes
Composite of mortality,
hospitalizations, VT/VF
Improvement in
6MWT
NYHA functional class
QOL
LVEF
LV volumes
rdiac Defibrillator; COMPANION  Comparison of Medical Therapy, Pacing and
icular; LVEDD  left ventricular end-diastolic dimension; LVEF  left ventricular
r InSync Randomized Clinical Evaluation; MIRACLE-ICD  Multicenter InSync
ultisite Simulation in Cardiomyopathies; NYHA  New York Heart Association;
fe score; VF  ventricular fibrillation; VO2  volume of oxygen; VT  ventricularmary
ction
ction
ortal
zation
ortal
ction
K-Ca
ventr
ticente
 MRS duration150 ms (as compared to patients with QRS
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Issues Before Device Implantation December 20, 2005:2153–67uration 120 to 150 ms) (13). These observations tend to
upport the use of the QRS duration for patient selection.
owever, careful analysis of the individual patients in many
RT studies demonstrated that 20% to 30% of the patients
ailed to respond to CRT, despite prolonged QRS duration.
n particular, Reuter et al. (14) evaluated 102 patients
ndergoing CRT and reported non-response in 18% of
atients. These observations prompted Molhoek et al. (15)
o analyze the precise value of the QRS duration to predict
esponse to CRT. Their study included 61 patients, and 45
74%) responded to CRT. The QRS duration at baseline
efore pacing was similar between the responders and
on-responders (179  30 ms vs. 171  32 ms; p  NS).
owever, a significant shortening in QRS duration after six
onths of CRT was observed only in responders. Receiver
perating characteristic curve analysis showed that a reduc-
ion in QRS duration 10 ms had a high sensitivity (73%)
ith low specificity (44%) (Fig. 1) in prediction of respond-
rs. Conversely, a reduction in QRS duration 50 ms was
ighly specific (88%) but not sensitive (18%) to predict
esponse to CRT. Comparable findings were recently re-
orted by Lecoq et al. (16).
igure 1. Receiver operating characteristic curve analysis on the change in
RS duration after six months of cardiac resynchronization therapy (CRT)
able 2. Markers of Chronic Response to CRT
linical parameters
NYHA functional class
Quality-of-life score
6-min walk distance, exercise capacity peak VO2
(Heart failure) hospitalizations
(Cardiac) mortality
chocardiographic parameters
Left ventricular ejection fraction
Left ventricular dimensions/volumes
Mitral regurgitation
Interventricular resynchronization
Left ventricular resynchronization
RT  cardiac resynchronization therapy; NYHA  New York Heart Association;
O2  volume of oxygen.r
emonstrated an optimal sensitivity of 58% and 56% (using a cutoff value
f 30 ms) to predict response to CRT. Adapted from Molhoek et al. (15).It has subsequently been suggested that intraventricular
yssynchrony may predict response to CRT more accurately
10). In this respect, studies using TDI demonstrated that
atients with intraventricular dyssynchrony had a high
ikelihood of a positive response to CRT (10). Bleeker et al.
17) evaluated the relation between QRS duration and LV
yssynchrony (assessed by TDI) in 90 patients with severe
eart failure; LVEF 35%; and narrow (120 ms), inter-
ediate (120 to 150 ms), or wide (150 ms) QRS com-
lexes. Substantial LV dyssynchrony on TDI was present in
7%, 60%, and 70% of patients, respectively. When QRS
uration was considered as a continuous variable, no relation
etween QRS duration and LV dyssynchrony could be dem-
nstrated (Fig. 2). Ghio et al. (18) confirmed the absence of
V dyssynchrony in 48% of patients with an intermediate
120 to 150 ms) QRS complex and in 28% of patients with
wide (150 ms) QRS complex. These observations
ndicate that patients with a wider QRS complex have a
igher likelihood of LV dyssynchrony, although 30% of
atients with wide (150 ms) QRS complex lack LV
yssynchrony. This 30% may partially explain a similar
ercentage of non-responders in the large trials. These
bservations have resulted in many echocardiographic stud-
es evaluating different echocardiographic parameters to
etect LV dyssynchrony and predict response to CRT.
CHOCARDIOGRAPHIC SELECTION
F RESPONDERS TO CRT: ROLE OF
NTERVENTRICULAR DYSSYNCHRONY
chocardiography is the most practical approach to evaluate
yssynchrony and predict response to CRT. Initial studies
ave focused on assessment of interventricular (left-right)
yssynchrony to predict response. Interventricular dyssyn-
hrony can be evaluated by pulsed-wave Doppler echocar-
iography assessing the extent of interventricular mechani-
al delay defined as the time-difference between left and
igure 2. The QRS duration does not relate with the extent of left
entricular (LV) dyssynchrony as assessed with tissue Doppler imaging.
dapted from Bleeker et al. (17).ight ventricular pre-ejection intervals; a delay of 40 ms or
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December 20, 2005:2153–67 Issues Before Device Implantationore has been proposed as a marker of interventricular
yssynchrony (10). Bordachar et al. (19), however, reported
hat interventricular dyssynchrony was not related to hemo-
ynamic improvement during CRT.
Tissue Doppler imaging has also been used to assess
nterventricular dyssynchrony (11,20,21). Three studies used
DI to compare the delay between peak systolic velocity
f the right ventricular free wall and the LV. Although
enicka et al. (21) suggested that assessment of interventric-
lar delay by TDI contributed to the prediction of response to
RT, this was not confirmed by two different studies where
DI was used (11,20). Bax et al. (20) evaluated 80 patients
ndergoing CRT and demonstrated a similar extent of inter-
entricular dyssynchrony in the 59 responders and the 21
on-responders (47  34 ms vs. 49  29 ms; p  NS). Yu
t al. (11) demonstrated that interventricular dyssychrony
as not predictive of response to CRT in 54 patients
ndergoing CRT. Thus, most evidence suggests that inter-
entricular dyssynchrony is not useful in the prediction of
esponse to CRT.
CHOCARDIOGRAPHIC SELECTION OF RESPONDERS
O CRT: ROLE OF LV DYSSYNCHRONY ON M-MODE,
WO-DIMENSIONAL ECHOCARDIOGRAPHY, AND TDI
variety of echocardiographic techniques have been sug-
ested for the assessment of LV dyssynchrony and predic-
ion of response to CRT. These techniques include M-mode
ssessment, two-dimensional echocardiography using phase
maging or intravenous contrast, TDI, and potentially
hree-dimensional echocardiography (10). Tissue Doppler
maging is the most extensively tested technique, and
ifferent methods have been proposed, including pulsed-
ave TDI, color-coded TDI, tissue tracking, displacement
apping, strain and strain rate imaging, and, most recently,
issue synchronization imaging (TSI). A comprehensive
ummary of the merits of the different techniques to predict
esponse to CRT is provided in Table 3.
-mode echocardiography. Using an M-mode recording
rom the parasternal short-axis view (at the level of the
apillary muscles), the septal-to-posterior wall motion delay
an be obtained, and a cutoff value of 130 ms or more was
roposed as a marker of intraventricular dyssynchrony. Pitzalis
t al. (22) evaluated 20 patients and reported a sensitivity and
pecificity of 100% and 63%, respectively, to predict re-
ponse to CRT. In addition, the authors recently demon-
trated the prognostic value of the septal-to-posterior wall
otion delay (23). However, this parameter is often difficult
o obtain. Rose et al. (24) evaluated the feasibility of
btaining this parameter in the patients of the
ONTAK-CD database. A clear definition of the systolic
eflection of both the septal and posterior wall was possible
n only 45% of 79 patients. Moreover, the septal-to-
osterior wall motion delay did not correlate with LV
everse remodeling. Most importantly, the sensitivity and
pecificity to predict response (both clinical and echocardio- sraphic) were 24% and 66%. These findings were similar in
atients with ischemic and dilated cardiomyopathy.
wo-dimensional echocardiography. The first use of
wo-dimensional echocardiography was that of a semiauto-
atic method for endocardial border delineation (25). The
egree of LV dyssynchrony was quantified in two-
imensional echocardiographic sequences from the apical
our-chamber view, focusing on the septal-lateral relation-
hips. Computer-generated regional wall movement curves
ere compared by a mathematical phase analysis, based on
ourier transformation. The resulting septal-lateral phase
ngle difference is a quantitative measure for intraventricular
dys)synchrony. Using this approach, patients with exten-
ive LV dyssynchrony between the septum and lateral wall
xhibited an immediate improvement in hemodynamics
fter CRT. The second approach utilized echo contrast
Optison, Mallinckrodt, Hazelwood, Missouri) to optimize
V border detection (26). With the improved LV border
etection, regional fractional area changes were determined
nd plotted versus time, yielding displacement maps. From
hese maps, the LV dyssynchrony between the septum and
ateral wall was determined. The authors observed an acute
eduction in LV dyssynchrony after biventricular pacing,
hich correlated with an acute increase in LVEF. No
tudies on the two-dimensional techniques for prediction of
ong-term outcome have been published.
DI, strain, and strain rate imaging. Tissue Doppler
maging measures the velocity of longitudinal cardiac mo-
ion and allows comparison of timing of motion in relation
o electrical activity (QRS complex). Different parameters
an be derived, and the most frequently used include the
eak systolic velocity, the time to onset of systolic velocity,
nd the time to peak systolic velocity.
The TDI measurements can be obtained directly using
ulsed-wave TDI and using color-coded TDI, which needs
ost-processing. With pulsed-wave TDI, only one region
an be interrogated at a time making the procedure time-
onsuming and precludes comparison of segments simulta-
eously. Because measurements are influenced by differences
n heart rate, loading conditions and respiration measure-
ents that are not simultaneous may be less meaningful. In
ddition, the timing of peak systolic velocity is often difficult
o identify, resulting in imprecise information on LV
yssynchrony. There is limited evidence of pulsed-wave
DI to predict response to CRT. Two studies have dem-
nstrated a relation between LV dyssynchrony on pulsed-
ave TDI and improvement in symptoms and/or LVEF
fter CRT (27,28), but prediction of response was not
ddressed. Bordachar et al. (19) showed that LV dyssyn-
hrony assessed by pulsed-wave TDI correlated with an
mprovement in cardiac output and reduction in mitral
egurgitation after CRT. Penicka et al. (21) used pulsed-
ave TDI (with an integration of interventricular and LV
yssynchrony) and reported a sensitivity of 96% with a
pecificity of 77% to predict response to CRT.
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Issues Before Device Implantation December 20, 2005:2153–67able 3. Echocardiographic Studies on LV Dyssynchrony to Predict Response to CRT
Authors
Patients
(n)
Follow-Up
Period
(month)
Echo
Technique
Methodology for LV
Dyssynchrony Main Findings
Sensitivity
(%)
Specificity
(%)
itzalis et al. (22) 20 1 M-mode Septal-to-posterior wall
motion delay
Septal-to-posterior delay 130 ms
predicted LV reverse
remodeling
100 63
itzalis et al. (23) 60 14 M-mode Septal-to-posterior wall
motion delay
Septal-to-posterior delay 130 ms
predicted event-free survival
NA NA
ose et al. (24) 79 6 M-mode Septal-to-posterior wall
motion delay
Septal-to-posterior delay 130 ms
insufficient to predict LV
reverse remodeling
24 66
reithardt et al. (25) 34 Acute 2D phase
imaging
Difference between the
lateral and septal
wall motion phase
angles
Delayed lateral wall motion
predicted acute hemodynamic
improvement
NA NA
awaguchi et al. (26) 10 9 Contrast
echo
Septal and lateral
fractional area
changes
1 Septal inward motion,
2 spatial and temporal LV
dyssynchrony by 40%, and
correlated with 1 LVEF
NA NA
enicka et al. (21) 49 6 Pulsed-wave
TDI
Ts(onset) of 3 basal
LV and 1 basal RV
segments
Summation of inter- and
intra(LV)-ventricular delay
102 ms predicted 1 LVEF
96 71
nsalone et al. (27) 21 1 Pulsed-wave
TDI
Systolic dyssynchrony
among 5 basal
segments
Extensive LV dyssynchrony
resulted in 1 in symptoms, and
1 LVEF
NA NA
arrigue et al. (28) 12 12 Pulsed-wave
TDI
Ts(onset) between
septum and lateral
wall
Post-CRT reduction in LV
dyssynchrony and improvement
in symptoms
NA NA
ordachar et al. (19) 41 3 Pulsed-wave
TDI,
M-mode,
pulsed-
wave
Doppler
Maximal difference in
12 LV segments for
Ts, Ts(onset),
Ts-SD, and DLC
Maximal difference in 12 LV
segments for Ts, T(onset),
Ts-SD closely correlated with
improvement of MR and CO,
but not interventricular delay by
pulsed-wave Doppler echo
NA NA
u et al. (29) 25 3 Color-coded
TDI
Ts of 12 LV segments
in ejection phase
Improve LV dyssynchrony by
delaying Ts in 12 LV segments
globally resulting in
homogenous Ts
NA NA
ax et al. (30) 25 Acute Color-coded
TDI
Septal-to-lateral delay
of Ts in ejection
phase
Septal-to-lateral delay of Ts 60
ms predicted 1 LVEF
76 88
u et al. (31) 30 3 Color-coded
TDI
Ts-SD of 12 LV
segments in ejection
phase
Ts-SD of 12 LV segments 33
ms predicted LV reverse
remodeling
NA NA
ax et al. (20) 85 12 Color-coded
TDI
Septal-to-lateral delay
of Ts in ejection
phase
Septal-to-lateral delay of Ts 65
ms predicted LV reverse
remodeling; and associated with
lower event rate
92 92
otabartolo et al. (32) 49 3 Color-coded
TDI
Maximal difference in
Ts in 6 basal
segments (both
ejection phase and
post-systolic
shortening)
Maximal difference in Ts in
6 basal segments 110 ms
predicted reverse remodeling
97 55
u et al. (11) 54 3 Color-coded
TDI, SRI
Ts-SD of 12 LV
segments in ejection
phase (and 17 other
parameters)
Ts-SD of 12 LV segments 31
ms predicted LV reverse
remodeling
96 78
ogaard et al. (33) 20 12 Color-coded
TDI, SRI
DLC Number of basal segments with
DLC predicted 1 LVEF
NA NA
ogaard et al. (34) 20 Acute Color-coded
TDI, TT,
SRI
TT and DLC Optimization of V-V timing by
TT resulted in 2 DLC and
1 LVEF
NA NAContinued on next page
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December 20, 2005:2153–67 Issues Before Device ImplantationEight studies have used color-coded TDI to assess LV
yssynchrony and predict outcome (Table 3) (11,20,29–34).
rom these color-coded images, TDI tracings can be obtained
y post-processing, and the majority of studies have used
ime to peak systolic velocity to assess LV dyssynchrony.
nitially, investigators focused on the four-chamber view to
dentify LV dyssynchrony by color-coded TDI (Fig. 3).
elocity tracings were derived from the basal septal and
ateral segments, and the septal-to-lateral delay was mea-
ured. It was shown that a delay 60 ms was predictive of
cute response to CRT (30). Subsequently, a four-segment
odel was applied, which included four basal segments
septal, lateral, inferior, and anterior) (20). It was shown
hat a delay65 ms allowed prediction of response to CRT.
sing this cutoff value, sensitivity/specificity for prediction
f clinical improvement (defined by an improvement in
YHA functional class and 6-min walking distance) were
oth 80% whereas sensitivity/specificity for LV reverse
emodeling (defined as a 15% reduction in LV end-
ystolic volume) were both 92%. In addition, patients with
V dyssynchrony 65 ms had a favorable prognosis after
able 3. Continued
Authors
Patients
(n)
Follow-Up
Period
(month)
Echo
Technique
Method
Dyss
reithardt et al. (35) 18 Acute Strain, SRI Strain an
septal a
walls
un et al. (36) 34 Acute Displacement,
strain,
and SRI
Strain, SR
displac
septal a
walls
opovic´ et al. (37) 22 1–12 Displacement
and strain
Strain at
lateral
ohi et al. (38) 38 Acute TSI and
strain
Peak radi
septum
posteri
orcsan III et al. (39) 29 Acute TSI Septal-po
(both e
and po
shorten
u et al. (40) 56 3 TSI Ts-SD of
segmen
phase (
post-sy
shorten
hang et al. (43) 13 3 3D echo Time to
systolic
(Tmsv)
16 LV
O  cardiac output; CRT  cardiac resynchronization therapy; DLC  delayed l
R  mitral regurgitation; RV  right ventricular; SRI  strain rate imaging; TD
eak myocardial systolic velocity; TSI  tissue synchronization imaging; Ts(onse
o peak myocardial systolic velocity; TT  tissue tracking; V-V interventricular.RT. mThe extensive studies by Yu et al. (11,29,31) have used a
2-segment model. Tracings were derived from 12 seg-
ents, and an LV dyssynchrony index was derived from the
tandard deviation of all 12 time intervals demonstrating
hat a dyssynchrony index 31 ms yielded a sensitivity and
pecificity of 96% and 78% to predict LV reverse remodel-
ng (11). In general, prediction of response to CRT based
n time to peak systolic velocity (using a varying number of
egments) yields a high sensitivity (ranging from 76% to
7%) and specificity (ranging from 55% to 92%) (Table 3).
Seven studies have used tissue tracking, strain, and/or
train rate imaging (11,33–38). Tissue tracking (GE Ving-
ed, Horten, Norway) provides a color-coded display of
yocardial displacement, allowing for easy visualization LV
yssynchrony and the region of latest activation. Sogaard et
l. (34) pioneered this approach and demonstrated that the
umber of segments with delayed longitudinal contraction
as related to the improvement in LVEF during CRT.
Strain and strain rate analysis is performed by off-line
nalysis of the color-coded tissue Doppler images. Strain
nalysis allows direct assessment of the extent and timing of
for LV
rony Main Findings
Sensitivity
(%)
Specificity
(%)
at
teral
Baseline: lateral wall strain and
strain rate higher than septal;
CRT: septal wall strain and
strain rate higher than lateral
NA NA
d
t at
teral
1 LVEF and 1 peak strain rate
at lateral wall by CRT; 1
Septal and inferior wall
displacement by LV pacing
NA NA
and 1 Global LV peak strain, 2
coefficient of change in LV
strain, no change in septal or
lateral wall displacement
NA NA
in
s
ll
Delay in septal-posterior strain
130 ms, predicted 1 stroke
volume
95 88
r delay
n phase
tolic
Septal-posterior delay 65 ms
predicted 1 stroke volume
87 100
V
ejection
ion of
Ts-SD of 12 LV segments in
ejection phase 34 ms
predicted reverse LV
remodeling
87 81
al
me
, 12, and
ents
Improvement of Tmsv parameters
during CRT Tmsv of 16 LV
segments by 3D echo correlated
closely with Ts-SD of 12 LV
segments by TDI
NA NA
dinal contraction; LV  left ventricular; LVEF  left ventricular ejection fraction;
ssue Doppler imaging; TMSV  time to minimal systolic volume; Ts  time to
me to onset of myocardial systolic velocity; Ts-SD  standard deviation of timeology
ynch
d SRI
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I, an
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Issues Before Device Implantation December 20, 2005:2153–67he percentage of segmental shortening or lengthening in
elation to its original length (10). The main advantage over
DI is that strain analysis allows differentiation between
ctive systolic contraction and passive motion. This is
igure 3. Color-coded four-chamber tissue Doppler image (upper left). Po
s present as indicated by the delay in the peak systolic velocity of the sep
igure 4. Tissue synchronization imaging, four-chamber view. (Left) T
olor-guided visual identification of the site of latest activation facilitates sn this patient, the earliest activation (green) is in the lateral wall, and the late
onfirm the delay between the septum and lateral wall.mportant in patients with ischemic cardiomyopathy with
he presence of scar tissue. Breithardt et al. (35) showed that
RT reversed the pathologic septal-lateral strain relation-
hips and reduced the incidence of early systolic pre-stretch
cessing yields velocity tracings (right); severe left ventricular dyssynchrony
yellow curve) as compared to the lateral wall (green curve).
olor represents timing: green  normal timing; red  severe delay.
e-placement to derive the tissue Doppler imaging (TDI) velocity tracings.st-prohe c
amplst activation is in the lateral wall (red); the TDI velocity tracings (right)
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December 20, 2005:2153–67 Issues Before Device Implantationn the late activated wall and of post-systolic shortening.
owever, no study with strain or strain rate imaging has so
ar reported on the actual prediction of response to CRT
Table 3), except for Yu et al. (11), who demonstrated that
train rate imaging could not predict LV reverse remodel-
ng. Despite the technical advantages of the strain imaging,
igure 5. Four-dimensional tissue synchronization imaging (TSI) of a nor
f the left ventricle is reconstructed (middle). The entire three-dimensional
llows the display of the different segments in a polar map format (right)
igure 6. Four-dimensional tissue synchronization imaging (TSI) of a
hree-dimensional impression of the left ventricle is reconstructed (middle
olar-map format (upper right) indicating in red the site of latest activation (
urther quantify the extent of left ventricular dyssynchrony using different paramhe technique has not become routine practice in the
valuation of patients considered for CRT. The main
imitations are the time-consuming aspect of the technique,
he high operator dependency, and the moderate reproduc-
bility. Only one direct comparison between TDI and strain
ate imaging has been reported in 54 patients undergoing
ndividual. From the different views (left), a three-dimensional impression
e of the left ventricle is green indicating no dyssynchrony. Post- processing
rther facilitate identification of the site of latest activation.
t with left ventricular dyssynchrony. From the different views (left), a
e region of latest activation is indicated in red. Post-processing yields themal i
imag
to fupatien
). Thanteroseptal), and further calculations can be performed (lower right) to
eters.
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Issues Before Device Implantation December 20, 2005:2153–67RT (11). Left ventricular dyssynchrony on TDI was
redictive of LV reverse remodeling, but strain rate imaging
ailed to predict response to CRT (11).
SI TO ASSESS LV DYSSYNCHRONY
recent addition to the tissue Doppler approach to quan-
ify LV dyssynchrony has been the automated color-coding
f time to peak longitudinal velocities. This color-coding of
emporal velocity data is superimposed on the routine
wo-dimensional echocardiographic images to provide vi-
ual mechanical information on the anatomical regions.
issue synchronization imaging (GE Vingmed) (38–40) is
signal-processing algorithm of the tissue Doppler data to
utomatically detect peak positive velocity and then color-
ode the time to peak velocities in green for normal timing,
ellow-orange for moderate delay, and red for severe delays
n peak longitudinal velocity (Fig. 4). Interval start time is
anually fine-tuned to begin with aortic valve opening to
xclude isovolumic contraction velocity and extended to
apid filling (E-wave) to include post-systolic LV dyssyn-
igure 7. Real-time three-dimensional full volume analysis of regional left
he bulls-eye display (bottom left) of the 16 segments. Changes in regiona
ight. The anteroseptal and septal segments (light blue and green) show
o other segments. A first derivative display of the regional volume curves
n the timing of minimal regional volume (indicated by the zero crossinghrony; TSI color-coding is then used to guide placement of t 15 mm oval regions of interest in the basal and
id-segments from apical views. Regions of interest are
ocalized where the color-coding of timing is most repre-
entative for the anatomical segment for time-velocity curve
nalysis. Although the color-coding information is very
seful, it is considered important to continue to use the
ime-velocity tracings to correctly identify the peak veloci-
ies for LV dyssynchrony analysis. Left ventricular dyssyn-
hrony can be defined as difference in time to peak velocity
f opposing walls: inferoseptal to lateral wall (four-chamber
iew), anterior to inferior wall (two-chamber view), and
nteroseptal to posterior wall (long-axis view). In a pilot
eries of 29 patients, TSI was assessed before CRT, and
cute response (defined as an immediate increase in LV
troke volume by 15% or more) was observed in 21 patients
39). Differences in baseline TSI time to peak velocity of
pposing LV walls (three views average) were greater in
cute responders than non-responders: 120 148 ms versus
5  153 ms (p  0.05). When delays between individual
alls were compared, dyssynchrony between the anterosep-
cular function showing (top left) the reconstructed left ventricular cast and
me (color-matched) for each of the 16 segments is displayed in the upper
function and significant delay in achieving a minimum volume compared
wn in the lower right panel and also demonstrates significant dispersion
s).ventri
l volu
poor
is sho
pointal and posterior wall (assessed from the apical long-axis
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December 20, 2005:2153–67 Issues Before Device Implantationiew) had the greatest ability to separate acute responders
rom non-responders after CRT. A cutoff value of 65 ms
ad a sensitivity and specificity of 87% and 100%, respec-
ively, to predict acute response to CRT (39). The cutoff
alue of 65 ms is in agreement with other results (20) using
olor-coded TDI. In addition, a recent study by Yu et al.
40) used TSI in 56 patients to predict LV reverse remod-
ling after three months of CRT, and a sensitivity of 87%
ith a specificity of 81% was demonstrated.
Recent technological enhancements include multiplane
SI imaging to keep frame rates high with three-
imensional reconstruction of color-coded temporal LV
ctivation; imaged in the time-domain, this allows actual
our-dimensional information. Examples of four-dimensional
SI in a normal individual and a patient with LV dyssyn-
hrony are demonstrated in Figures 5 and 6. Angle-
orrected tissue Doppler data for color-coded temporal
ctivation, known as Dyssynchrony Imaging (Toshiba, To-
yo, Japan), also have the potential to provide radial
yssynchrony data that may be additive to dyssynchrony
nalysis of longitudinal velocities alone. In 38 patients under-
oing CRT, Dohi et al. (38) showed a sensitivity of 95% with
specificity of 88% to predict acute response to CRT using
igure 8. Parametric polar-map displays (lower left and lower right pane
lue indicates early activation, red indicates late activation. Left ventricular
nteroseptal region (red, lower left panel); almost complete resynchronizatadial dyssynchrony. CHREE-DIMENSIONAL ECHOCARDIOGRAPHY
O ASSESS LV DYSSYNCHRONY
hree-dimensional echocardiography has evolved from a
echnique based on reconstruction of multiple two-
imensional scan planes to an almost real-time methodology.
eft ventricular volumes and LVEF can be assessed with
igh accuracy (41). In the context of LV dyssynchrony,
nalysis of regional function in the time-domain is impor-
ant (10), and a series of plots is obtained representing the
hange in volume for each segment (usually 16 or 17
egments) throughout the cycle (Fig. 7). With synchronous
ontraction of all segments, each segment would be ex-
ected to achieve the minimum volume at almost the same
oint in the cardiac cycle. In LV dyssynchrony, dispersion
xists in the timing of the point of minimum volume for
ach of the segments. The degree of dispersion reflects the
everity of LV dyssynchrony (42).
Parametric “polar-map” displays (of the three-dimensional
ata) of the timing of LV contraction have been developed to
acilitate interpretation of data. This methodology examines
egional LV contraction at approximately 3,000 points over
he endocardial surface rather than in 16 or 17 segments.
left ventricular dyssynchrony of the real-time three-dimensional images;
nchrony is present before cardiac resynchronization therapy (CRT) in the
as occurred after CRT, with disappearance of “red” regions (lower right).ls) ofolor-coding is used to identify the region/site of latest
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Issues Before Device Implantation December 20, 2005:2153–67ctivation, and this is potentially useful for electrophysiolo-
ists to select the optimal LV lead position. Examples of
arametric polar-map images (of the three-dimensional
ata) pre- and post-CRT are displayed in Figure 8. Zhang
t al. (43) used three-dimensional echocardiography in 13
atients who had previously received CRT; when CRT was
ithheld, significant LV dyssynchrony occurred, associated
ith a decrease in LVEF. Currently, no extensive data are
vailable on the prediction of response to CRT using
hree-dimensional echocardiography.
THER FACTORS RELATED TO RESPONSE:
ENOUS ANATOMY AND SCAR TISSUE
esides LV dyssynchrony, other factors are important for
uccess of CRT. In particular, the venous anatomy is
mportant. Considerable variability exists in the venous
ystem (44) as well as variability in the nomenclature used to
esignate specific coronary veins. The authors evaluated
enous anatomy by retrograde venography in 129 consecu-
igure 9. Noninvasive multislice computed tomography of the venous
ultiplanar curved reconstruction (MPR) of the coronary sinus (CS). Ind
nterventricular vein (PIV), the posterior vein of the left ventricle (PVLV),
right atrium; RV  right ventricle.
igure 10. Resting single-photon emission computed tomography image
erolateral infarction. A severe defect in tracer uptake is visible on the mid-ventr
hich is confirmed on the horizontal long-axis (HLA) (middle) and vertical loive patients referred for implantable cardioverter defibril-
ator implantation. In 5 (4%) patients coronary sinus cannu-
ation failed, and in 38 (29%) visualization was suboptimal
nd/or venograms were incomplete. In the remaining 86
atients, the anterior interventricular vein and middle car-
iac vein could be visualized in 99% and 100% of patients,
espectively. The veins (posterior or left marginal veins)
etween these two veins are mostly used for LV lead
lacement in CRT. Only one prominent vein was present in
1% of patients, two veins in 46% of patients, whereas more
han two veins were present in only 2% of patients. When
atients would be considered for CRT only in the presence
f the posterior veins, 55% would be acceptable. When
atients would be considered for CRT in the presence of the
osterior or the left marginal veins, 99% would be accept-
ble. Ideally, venous anatomy should be assessed non-
nvasively, at the outpatient clinic, to determine whether a
ransvenous approach is feasible, or whether a (minimal
nvasive) surgical approach should be used for LV lead
y. (Left) Three-dimensional volume rendered reconstruction. (Right)
on the three-dimensional reconstruction (left) are the CS, the posterior
the great cardiac vein (GCV). LA  left atrium; LV  left ventricle; RA
ng technetium-99m tetrofosmin) of a patient with a previous inferopos-anatom
icateds (usi
icular short-axis slice (SA) (left) in the inferior and posterolateral regions,
ng-axis (VLA) (right) projections.
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December 20, 2005:2153–67 Issues Before Device Implantationmplantation. The feasibility of multislice computed tomog-
aphy (MSCT) to visualize the venous anatomy was recently
emonstrated (45). The variability in venous anatomy was
onfirmed, and findings were in line with previous invasive
bservations; MSCT allowed not only precise determina-
ion of coronary sinus and its tributaries, but also assessment
f distances between veins and ostial size of the coronary
inus. An example of an MSCT depicting venous anatomy
s demonstrated in Figure 9.
Although information on venous anatomy is needed, it is
eally the integrated information on the site of latest
ctivation (maximum LV dyssynchrony) and venous anat-
my that determines the approach for LV lead implantation
transvenous versus surgical). Accordingly, it would be
esired for example to fuse the three-dimensional TSI
mages (Figs. 5 and 6) with the MSCT images (Fig. 9), in
rder to co-registrate electromechanical delays with venous
natomy.
Another factor that is important for success of CRT is
hether scar tissue is present in the region of latest
ctivation (where the LV lead should be positioned).
urrently, no solid data on this issue are available. One
necdotal report, however, demonstrated that initial re-
ponse to CRT was reversed after acute infarction in the
erritory of the LV lead (46). It would, therefore, be of
otential interest to evaluate non-invasively, before CRT
mplantation, whether the target region for LV lead
ositioning contains viable tissue or whether scar tissue is
resent. Various techniques are available, including nu-
lear imaging techniques, echocardiographic techniques,
r cardiovascular magnetic resonance (CMR). Routine
esting single-photon emission computed tomography
maging with a technetium-99m-labeled tracer would
rovide the requested information, as indicated in Figure
0, showing a large defect in the inferior and posterolat-
ral regions, indicating scar tissue. Contrast-enhanced
igure 11. Contrast-enhanced cardiovascular magnetic resonance short-a
on-transmural scar tissue in the posterolateral wall as indicated by th
osterolateral region.MR may eventually provide the optimal information, fecause it allows precise depiction of the extent, and
ransmurality of scar tissue (Fig. 11).
ONCLUSIONS
n large clinical trials, the beneficial effect of CRT has been
emonstrated. On an individual basis, however, 20% to 30%
f patients still do not respond to CRT. Observational
chocardiographic studies have clearly demonstrated that
he presence of LV dyssynchrony is an important factor
etermining response to CRT, whereas interventricular
yssynchrony appears of less importance. Various studies
sing different echocardiographic approaches have subse-
uently aimed at prediction of response to CRT, and the
vailable literature suggests that TDI using 2-, 4-, or
2-segment models of LV dyssynchrony may represent the
est method to predict response to CRT. Careful analysis of
he literature also reveals the limitations of published
tudies. The number of patients is small in most studies, a
ack of consensus exists in assessment of response (in
articular clinical parameters vs. echocardiographic param-
ters), the measurements of LV dyssynchrony are different
mong studies, and direct comparisons between LV dyssyn-
hrony parameters to predict response are virtually absent.
he Predictors of Response to Cardiac Resynchronization
herapy (PROSPECT) study is underway to examine if
rospectively defined echocardiographic parameters of sys-
olic dyssynchrony are able to predict a favorable response to
RT, and the latter includes both clinical composite end
oints and LV reverse remodeling (47). Still, from the
xisting evidence, it appears mandatory to expand current
uidelines for patient selection for CRT, and to include
ssessment of LV dyssynchrony.
In addition to LV dyssynchrony, information on venous
natomy and the presence of scar tissue may further opti-
ize response to CRT, but further studies are needed to
ces illustrating the presence and transmural extent of scar tissue. (Left)
erenhanced (white) region. (Right) Transmural scar formation in thexis sli
e hypully appreciate the clinical importance of these issues.
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